Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease
Recompensation has gained increasing attention in the field of cirrhosis, particularly in
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
chronic liver disease with a definite aetiology. The current global prevalence of obesity and …
Effect of treatment with direct-acting antiviral agents on the prognosis of extrahepatic diseases in patients with hepatitis C
L ZHANG - 临床肝胆病杂志, 2024 - lcgdbzz.org
The prognosis of patients with hepatitis C virus infection depends not only on liver lesions,
but also on extrahepatic sequelae. Direct-acting antiviral agents (DAAs), as the first-line …
but also on extrahepatic sequelae. Direct-acting antiviral agents (DAAs), as the first-line …
直接抗病毒药物治疗对丙型肝炎患者肝外疾病预后的影响.
王晓燕， 张缭云 - Journal of Clinical Hepatology/Linchuang …, 2024 - search.ebscohost.com
HCV 感染者的预后不仅取决于肝脏病变, 还取决于肝外后遗症. 直接抗病毒药物(DAAs)
作为当前治疗丙型肝炎的一线用药, 使越来越多的患者获得持续病毒学应答及临床治愈 …
作为当前治疗丙型肝炎的一线用药, 使越来越多的患者获得持续病毒学应答及临床治愈 …
Significance of vascular cell adhesion molecule-1 and tumor necrosis factor-alpha in HIV-infected patients
T Mikuła, M Suchacz, M Sapuła… - Journal of Clinical …, 2022 - mdpi.com
Background. The aim of this study was the evaluation of the correlation between VCAM-1
and TNF-alpha serum concentrations and various clinical and laboratory parameters in HIV …
and TNF-alpha serum concentrations and various clinical and laboratory parameters in HIV …
Evaluation of the Safety Profile of Direct-Acting Antivirals on Patients with Hepatitis C Virus: A Pharmacovigilance Study
MG El-Marakby, MH Solayman, NA Sabri - Therapeutic Innovation & …, 2023 - Springer
Abstract Background Hepatitis C virus (HCV) is the primary contributor to chronic hepatic
diseases. A rapid change in the situation took place with the advent of oral direct-acting …
diseases. A rapid change in the situation took place with the advent of oral direct-acting …